Suppr超能文献

Variable presentations of rare genetic renal interstitial diseases.

作者信息

Trachtman Howard

机构信息

Division of Nephrology, Department of Pediatrics, New York University Langone Medical Center, New York, New York.

出版信息

Clin J Am Soc Nephrol. 2014 Mar;9(3):437-9. doi: 10.2215/CJN.00180114. Epub 2014 Feb 7.

Abstract
摘要

相似文献

1
Variable presentations of rare genetic renal interstitial diseases.
Clin J Am Soc Nephrol. 2014 Mar;9(3):437-9. doi: 10.2215/CJN.00180114. Epub 2014 Feb 7.
2
Autosomal Dominant Tubulointerstitial Kidney Disease Due to MUC1 Mutation.
Am J Kidney Dis. 2018 Apr;71(4):495-500. doi: 10.1053/j.ajkd.2017.08.024. Epub 2017 Dec 6.
3
Autosomal dominant tubulointerstitial kidney disease: a new tool to guide genetic testing.
Kidney Int. 2020 Sep;98(3):549-552. doi: 10.1016/j.kint.2020.05.046.
5
Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.
Am J Kidney Dis. 2018 Sep;72(3):411-418. doi: 10.1053/j.ajkd.2018.03.019. Epub 2018 May 18.
6
Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.
Clin J Am Soc Nephrol. 2014 Mar;9(3):527-35. doi: 10.2215/CJN.06380613. Epub 2014 Feb 7.
8
Development and Validation of a Mass Spectrometry-Based Assay for the Molecular Diagnosis of Mucin-1 Kidney Disease.
J Mol Diagn. 2016 Jul;18(4):566-71. doi: 10.1016/j.jmoldx.2016.03.003. Epub 2016 May 5.
9
Noninvasive Immunohistochemical Diagnosis and Novel Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.
J Am Soc Nephrol. 2018 Sep;29(9):2418-2431. doi: 10.1681/ASN.2018020180. Epub 2018 Jul 2.
10
A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies.
Trends Mol Med. 2021 Apr;27(4):394-409. doi: 10.1016/j.molmed.2020.11.008. Epub 2020 Dec 16.

本文引用的文献

1
Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.
Clin J Am Soc Nephrol. 2014 Mar;9(3):527-35. doi: 10.2215/CJN.06380613. Epub 2014 Feb 7.
2
Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.
J Am Soc Nephrol. 2014 Jan;25(1):18-32. doi: 10.1681/ASN.2013040398. Epub 2013 Dec 12.
4
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
Am J Kidney Dis. 2013 Aug;62(2):253-60. doi: 10.1053/j.ajkd.2013.03.013. Epub 2013 Apr 22.
6
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
Clin J Am Soc Nephrol. 2013 Apr;8(4):554-62. doi: 10.2215/CJN.04760512. Epub 2013 Jan 10.
7
Chronic kidney disease 10 years on: what have we learned?
Curr Opin Nephrol Hypertens. 2012 Nov;21(6):607-11. doi: 10.1097/MNH.0b013e328358a30e.
8
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.
PLoS Genet. 2011 Sep;7(9):e1002292. doi: 10.1371/journal.pgen.1002292. Epub 2011 Sep 29.
9
Hereditary interstitial kidney disease.
Semin Nephrol. 2010 Jul;30(4):366-73. doi: 10.1016/j.semnephrol.2010.06.003.
10
Uromodulin levels associate with a common UMOD variant and risk for incident CKD.
J Am Soc Nephrol. 2010 Feb;21(2):337-44. doi: 10.1681/ASN.2009070725. Epub 2009 Dec 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验